Drug
TAK-101 clinical trials
Also written TAK-101.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2018 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses TAK-101 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free DietCompletedPhase 2TakedaNCT04530123Written as TAK-101
- Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac DiseaseCompletedPhase 2TakedaNCT03738475Written as TIMP-GLIA
- Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac DiseaseCompletedPhase 1TakedaNCT03486990Written as TIMP-GLIA